|
|
Volumn 21, Issue 2, 2010, Pages 431-432
|
|
VEGFR TKI 'resistance' or transient clinical insensitivity to VEGFR TKI in metastatic renal cell carcinoma
a,b,c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EVEROLIMUS;
PROTEIN TYROSINE KINASE INHIBITOR;
SORAFENIB;
SUNITINIB;
VASCULOTROPIN RECEPTOR;
ANTINEOPLASTIC AGENT;
BENZENESULFONIC ACID DERIVATIVE;
INDOLE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
ADULT;
ASTHENIA;
BRAIN METASTASIS;
CANCER GROWTH;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CASE REPORT;
DISEASE FREE SURVIVAL;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG ERUPTION;
DRUG RESPONSE;
DRUG WITHDRAWAL;
HAND FOOT SYNDROME;
HUMAN;
KIDNEY CARCINOMA;
LETTER;
LUNG METASTASIS;
LYMPH NODE METASTASIS;
METASTASIS;
MUCOSA INFLAMMATION;
MULTIPLE CYCLE TREATMENT;
NEPHRECTOMY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
SKIN MANIFESTATION;
STEREOTACTIC RADIOSURGERY;
TREATMENT OUTCOME;
TREATMENT PLANNING;
DRUG ADMINISTRATION;
DRUG ANTAGONISM;
DRUG RESISTANCE;
KIDNEY TUMOR;
MALE;
MIDDLE AGED;
PATHOLOGY;
PHYSIOLOGY;
TIME;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, RENAL CELL;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
INDOLES;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
PROTEIN KINASE INHIBITORS;
PYRIDINES;
PYRROLES;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
TIME FACTORS;
|
|
EID: 77951903245
PISSN: 09237534
EISSN: 15698041
Source Type: Journal
DOI: 10.1093/annonc/mdp548 Document Type: Letter |
|
Times cited : (19)
|
|
References (5)
|
